SCHEDULE 13G/AAccepted May 15, 6:41 PM ET
Avalo Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
6:41 PM
May 15, 2026
Filed
May 15, 2026
Documents
2
Size
21.7 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.